SAN DIEGO–(BUSINESS WIRE)–Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a strategic licensing collaboration with MLM Medical Labs, a global central and specialty laboratory with operations in Germany. Through the agreement, Amprion will license its proprietary seed amplification assay (SAA) methodology, the technology that powers its SAAmplify®-?SYN test, to enable ?-synuclein testing for biopharma-sponsored cli
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
